P3 Health Partners Inc

Company Profile

P3 Health Partners Inc had its IPO on 2021-04-06 under the ticker symbol PIII.

The company operates in the Healthcare sector and Medical Care Facilities industry. P3 Health Partners Inc has a staff strength of 600 employees.

Stock update

Shares of P3 Health Partners Inc opened at $2.34 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.31 - $2.94, and closed at $2.79.

This is a +17.72% increase from the previous day's closing price.

A total volume of 1,601,882 shares were traded at the close of the day’s session.

In the last one week, shares of P3 Health Partners Inc have increased by +31.6%.

P3 Health Partners Inc's Key Ratios

P3 Health Partners Inc has a market cap of $662.88 million, indicating a price to book ratio of 1.9225 and a price to sales ratio of 0.8157.

In the last 12-months P3 Health Partners Inc’s revenue was $1.14 billion with a gross profit of $-7753000 and an EBITDA of $-115775000. The EBITDA ratio measures P3 Health Partners Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, P3 Health Partners Inc’s operating margin was -17.84% while its return on assets stood at -10.78% with a return of equity of -82.31%.

In Q2, P3 Health Partners Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 22.1%.

P3 Health Partners Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.99 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into P3 Health Partners Inc’s profitability.

P3 Health Partners Inc stock is trading at a EV to sales ratio of 0.3717 and a EV to EBITDA ratio of -3.7236. Its price to sales ratio in the trailing 12-months stood at 0.8157.

P3 Health Partners Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$908.96 million

Total Liabilities

$250.40 million

Operating Cash Flow

$-1188000.00

Capital Expenditure

$1.19 million

Dividend Payout Ratio

0%

P3 Health Partners Inc ended 2024 with $908.96 million in total assets and $0 in total liabilities. Its intangible assets were valued at $908.96 million while shareholder equity stood at $-136166000.00.

P3 Health Partners Inc ended 2024 with $0 in deferred long-term liabilities, $250.40 million in other current liabilities, 31000.00 in common stock, $-328586000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $59.92 million and cash and short-term investments were $59.92 million. The company’s total short-term debt was $0 while long-term debt stood at $108.19 million.

P3 Health Partners Inc’s total current assets stands at $172.15 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $104.42 million compared to accounts payable of $9.20 million and inventory worth $5.58 million.

In 2024, P3 Health Partners Inc's operating cash flow was $-1188000.00 while its capital expenditure stood at $1.19 million.

Comparatively, P3 Health Partners Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.79

52-Week High

$6.54

52-Week Low

$0.7

Analyst Target Price

$5.38

P3 Health Partners Inc stock is currently trading at $2.79 per share. It touched a 52-week high of $6.54 and a 52-week low of $6.54. Analysts tracking the stock have a 12-month average target price of $5.38.

Its 50-day moving average was $2.17 and 200-day moving average was $2.23 The short ratio stood at 10.68 indicating a short percent outstanding of 0%.

Around 3017.5% of the company’s stock are held by insiders while 2271% are held by institutions.